Full View

Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of …

G Ntaios, V Papavasileiou, HC Diener, K Makaritsis… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—To assess whether the combined analysis of all phase III trials of
nonvitamin-K-antagonist (non-VKA) oral anticoagulants in patients with atrial fibrillation and …
被引用次数：195 相关文章

[引用][C] Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack

G Ntaios, V Papavasileiou, HC Diener, K Makaritsis… - Stroke - sonar.ch
Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and
Previous Stroke or Transient Ischemic Attack SONAR logo Log in Sign up EN English …
[PDF] archive.org

[PDF][PDF] Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack

G Ntaios, V Papavasileiou, HC Diener, K Makaritsis… - 2012 - scholar.archive.org
Background and Purpose—To assess whether the combined analysis of all phase III trials of
nonvitamin-K-antagonist (non-VKA) oral anticoagulants in patients with atrial fibrillation and …
[HTML] nih.gov

[HTML][HTML] Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta …

G Ntaios, V Papavasileiou, HC Diener… - Database of Abstracts …, 2012 - ncbi.nlm.nih.gov
This review concluded that non-vitamin-K-antagonist oral anticoagulants seem to be
associated with significant reductions in the rates of stroke or systemic embolism …
[PDF] academia.edu

[PDF][PDF] Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack

G Ntaios, V Papavasileiou, HC Diener, K Makaritsis… - 2012 - academia.edu
Background and Purpose—To assess whether the combined analysis of all phase III trials of
nonvitamin-K-antagonist (non-VKA) oral anticoagulants in patients with atrial fibrillation and …

[引用][C] Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack

G Ntaios, V Papavasileiou, HC Diener, K Makaritsis… - Stroke - folia.unifr.ch
Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and
Previous Stroke or Transient Ischemic Attack SONAR logo Log in Sign up EN English …

[引用][C] Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack: A Systematic Review and …

G NTAIOS, V PAPAVASILEIOU, HC DIENER… - Stroke …, 2012 - pascal-francis.inist.fr
Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and
Previous Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis of …

Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack

G Ntaios, V Papavasileiou, HC Diener, K Makaritsis… - Stroke, 2012 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background and Purpose—</jats: title>< jats: p> To assess
whether the combined analysis of all phase III trials of nonvitamin-K-antagonist (non-VKA) …

Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of …

G Ntaios, V Papavasileiou, HC Diener… - Stroke, 2012 - pubmed.ncbi.nlm.nih.gov
Background and purpose To assess whether the combined analysis of all phase III trials of
nonvitamin-K-antagonist (non-VKA) oral anticoagulants in patients with atrial fibrillation and …

Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack A Systematic Review and Meta …

G Ntaios, V Papavasileiou, HC Diener, K Makaritsis… - 2012 - ir.lib.uth.gr
Background and Purpose-To assess whether the combined analysis of all phase III trials of
nonvitamin-K-antagonist (non-VKA) oral anticoagulants in patients with atrial fibrillation and …